Immunohistochemical evaluation of RRM2 indicates that it has strong prognostic significance in some subsets of NSCLC patients (primarily women, non-smokers, and former smokers quitting longer than ten years) 15. Here, RRM2 is linked to non-small cell lung carcinoma.